SIC
TMDX icon

SJS Investment Consulting’s Transmedics TMDX Stock Holding History

SJS Investment Consulting’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$598 Buy
6
+2
+50% +$261 ﹤0.01% 1660
2025
Q4 		$487 Sell
4
-4
-50% -$502 ﹤0.01% 1531
2025
Q3 		$899 Buy
8
+1
+14% +$117 ﹤0.01% 1049
2025
Q2 		$939 Buy
+7
New +$769 ﹤0.01% 882

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SJS Investment Consulting's TMDX Position: Q1 2026 in Review

SJS Investment Consulting increased its Transmedics (TMDX) stake by 50% in Q1 2026, buying an estimated $261 and bringing the position to 6 shares worth $598. The position accounts for ﹤0.01% of the portfolio, ranked #1660.

SJS Investment Consulting first reported a position in TMDX in Q2 2025 and has held it in 4 quarters since. The position peaked at $939 in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • SJS Investment Consulting held 6 shares of Transmedics worth $598 as of Q1 2026.
  • SJS Investment Consulting bought 2 Transmedics shares in Q1 2026, an estimated $261.
  • Transmedics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q1 2026, its #1660 holding.
  • SJS Investment Consulting first reported a position in Transmedics in Q2 2025 and has held it in 4 quarters since.
  • SJS Investment Consulting's Transmedics position peaked at $939 in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.